Press release
The Biopharmaceutical Excipients Market to Reach $3.79 Billion by 2029, Merck KGaA, BASF SE, Avantor, & Evonik Industries AG are the Major Stakeholders - Arizton
Global Biopharmaceutical Excipients Market - Focused Insights 2024-2029
Curious to Know More About the Market? Click: https://www.arizton.com/market-reports/biopharmaceutical-excipients-market
Report Scope
Market Size (2029): $3.79 Billion
Market Size (2023): $2.43 Billion
CAGR (2023-2029): 7.67%
Historic Year: 2020-2022
Base Year: 2023
Forecast Year: 2024-2029
Market Segmentation: Excipient, Biologics, Scale of Operations, Origin, End-Users, and Geography
Stay ahead of the curve with Arizton's exclusive subscription plan, offering in-depth analysis, market sizing, and growth forecasts for less than $900 per month-a significant value compared to individual report purchases. Click here: https://www.arizton.com/subscription
The increasing demand for biopharmaceuticals is significantly driving the need for excipients in the production of biological drugs. As cancer and infectious diseases become more prevalent, there is a heightened need for vaccines, monoclonal antibodies, and other therapeutic solutions. Additionally, advances in various therapies are fueling the need for innovative and multifunctional excipients.
Growth of CMOs & CDMOs Segment
The CMOs (Contract Manufacturing Organizations) and CDMOs (Contract Development and Manufacturing Organizations) segment is experiencing notable growth, demonstrating the highest CAGR during the forecast period. Biopharmaceuticals, with their large molecular sizes and complex manufacturing processes, differ significantly from traditional small molecule drugs regarding behavior, production methods, and therapeutic effects. The complexities of biopharmaceutical manufacturing have led many biopharma companies to increasingly depend on CMOs and CDMOs for their specialized expertise and advanced capabilities.
Outsourcing to CMOs and CDMOs has become a preferred strategy among biopharma companies, as these organizations provide the specialized knowledge and infrastructure needed for efficient production. This allows biopharma developers to focus on product commercialization and clinical development while leveraging the manufacturing expertise of CMOs and CDMOs. The growing reliance on outsourcing and the expansion of new and existing product lines-including clinical trial supply services-has significantly contributed to the steady rise in CMO and CDMO sales.
Competitive Overview
The global biopharmaceutical excipients market report features data on 36 vendors, highlighting the diverse landscape of players ranging from emerging mid-sized companies to established industry leaders. Leading companies are employing a range of strategies to boost their market share and enhance their presence. These strategies include launching new products, securing regulatory approvals, engaging in marketing and promotional efforts, investing significantly in research and development, and strengthening distribution networks.
Significant players like Merck KGaA, BASF SE, Avantor, Evonik Industries, Roquette Freres, and Associated British Foods actively pursue strategic initiatives such as licensing agreements, acquisitions, and collaborations with emerging firms. These efforts enable them to rapidly enter the biopharmaceutical excipients market and gain access to commercially viable products. Companies also focus on expanding into existing and new markets to cater to a growing customer base, broadening their product portfolios, and enhancing production capabilities.
Additionally, there is a push towards introducing advanced and novel excipient solutions to support pharmaceutical drug development, alongside ensuring robust distribution chains to meet evolving market demands.
Buy this Research Now @ https://www.arizton.com/market-reports/biopharmaceutical-excipients-market
Key Vendors
*
Merck KGaA
*
BASF SE
*
Avantor
*
Evonik Industries AG
*
Roquette Freres
*
Associated British Foods plc
*
Actylis
*
Advancion
*
Apothecon Pharmaceuticals
*
Ashland
*
BioSpectra
*
BOC Sciences
*
CG Group
*
Clariant
*
Colorcon
*
DFE Pharma
*
Dow
*
Eastman Chemical Company
*
IMCD
*
Innophos
*
InVitria
*
ABITEC
*
CordenPharma
*
Croda International plc
*
JRS Pharma
*
Kirsch Pharma
*
MEGGLE
*
Novo Nordisk
*
Pfanstiehl
*
Shin-Etsu Chemical
*
Sigachi Industries
*
Spectrum Chemical
*
Stepan Company
*
Tereos
*
The Lubrizol Corporation
*
WACKER CHEMI
Segmentation & Forecast
Excipient
*
Bulking Agents
*
Solubilizers & Surfactants
*
Buffering & Tonicity Agents
*
Others
Biologics
*
Monoclonal Antibodies
*
Vaccines
*
Others
Scale of Operation
*
Commercial
*
Research
Origin
*
Organic Excipients
*
Inorganic Excipients
End-User
*
Pharma & Biotech Companies
*
CMOs & CDMOs
*
Academic & Research Institutes
Geography
*
North America
*
The U.S.
*
Canada
*
Europe
*
Germany
*
The U.K.
*
France
*
Italy
*
Spain
*
APAC
*
Japan
*
China
*
India
*
Australia
*
South Korea
*
Latin America
*
Brazil
*
Mexico
*
Argentina
*
Middle East & Africa
*
Turkey
*
South Africa
*
Saudi Arabia
Key Questions Answered in the Report:
How big is the global biopharmaceutical excipients market?
What is the growth rate of the global biopharmaceutical excipients market?
What are the key trends in the global biopharmaceutical excipients market?
Which region shows the highest growth in the global biopharmaceutical excipients market?
Who are the major players in the global biopharmaceutical excipients market?
Check Out Some of the Top Selling Research Reports:
IVD Contract Manufacturing Market - Global Outlook & Forecast 2024-2029
https://www.arizton.com/market-reports/ivd-contract-manufacturing-market
Europe Clinical Laboratory Tests Market - Focused Insights 2024-2029
https://www.arizton.com/market-reports/europe-clinical-laboratory-tests-market
Why Arizton?
100%Customer Satisfaction
24x7availability - we are always there when you need us
200+Fortune 500 Companies trust Arizton's report
80%of our reports are exclusive and first in the industry
100%more data and analysis
1500+reports published till date
Post-Purchase Benefit
*
1hr of free analyst discussion
*
10% off on customization
About Us:
Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.
Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.
Media Contact
Company Name: Arizton Advisory & Intelligence
Contact Person: Jessica
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=the-biopharmaceutical-excipients-market-to-reach-379-billion-by-2029-merck-kgaa-basf-se-avantor-evonik-industries-ag-are-the-major-stakeholders-arizton]
Phone: +1 3122332770
Country: United States
Website: https://www.arizton.com/market-reports/biopharmaceutical-excipients-market
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Biopharmaceutical Excipients Market to Reach $3.79 Billion by 2029, Merck KGaA, BASF SE, Avantor, & Evonik Industries AG are the Major Stakeholders - Arizton here
News-ID: 3614623 • Views: …
More Releases from ABNewswire
VIP Auto PA: Auto Brokers Near Me Redefine Transparent Car Leasing in Feastervil …
VIP Auto PA continues serving Pennsylvania with transparent, factory-direct car leasing services from its Feasterville-Trevose location, offering zero-down options and no-haggle pricing across all vehicle makes and models.
Feasterville-Trevose, PA - The traditional car-buying experience has long frustrated consumers with high-pressure sales tactics and inflated pricing structures. VIP Auto PA [http://www.vipautopa.com/] continues addressing these industry pain points through a customer-centric brokerage model that has served Pennsylvania drivers since 2007. Operating from…
Austin Nail Salon Dream Spa Expands Service Menu with Apres Gel-X and Holistic W …
Dream Spa in Austin expands with Apres Gel-X nails, infrared sauna, and head spa treatments, offering comprehensive beauty and wellness services at its Airport Boulevard location near downtown Austin.
Dream Spa [https://www.dreamspaatx.com/], located at 5301 Airport Blvd, Suite 200 in Austin, Texas, has announced the expansion of its service offerings to include authentic Apres Gel-X nail extensions, infrared sauna therapy, and signature head spa treatments. The locally established business continues to…
Terrance Private Investigator Expands Houston Private Investigator Services with …
Terrance Private Investigator launches a Houston community program offering consultation, family case support, and professional investigation services to residents facing sensitive personal matters.
A Houston-based investigative firm is taking action to support families facing difficult personal situations. Terrance Private Investigator & Associates [https://piterrance.com/] has announced a new community initiative designed to provide accessible resources and confidential case consultations for residents throughout the Houston area.
The program addresses growing concerns among families facing…
El Monte Agency Strengthens Home Insurance Options and Community Protection Serv …
Marvin Martinez: Allstate Insurance strengthens El Monte's insurance options with bilingual services, comprehensive coverage, and community-focused customer education, earning Elite Agent recognition through consistent service excellence.
El Monte, California - The local insurance landscape continues to evolve as Marvin Martinez, of Allstate Insurance [https://agents.allstate.com/marvin-martinez-el-monte-ca.html?utm_source=GMB&utm_medium=Website], reinforces the company's commitment to protecting families and businesses throughout the San Gabriel Valley. The agency's focus on personalized coverage solutions has positioned it as a trusted…
More Releases for Excipient
Chronic Disease Rise Fuels Albumin Excipient Market Growth: The Driving Engine B …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Albumin Excipient Market Size Growth Forecast: What to Expect by 2025?
The size of the albumin excipient market has been witnessing significant growth in recent years. It is estimated to rise from $4.85 billion in 2024 to $5.15 billion in 2025 with a Compound Annual Growth Rate (CAGR) of…
Biological Excipient Market Key Drivers for 2025
The Biological Excipient market is a crucial segment of the pharmaceutical industry, providing essential support for the efficacy and stability of drug formulations. Biological excipients are naturally derived substances that facilitate the delivery of active pharmaceutical ingredients (APIs), ensuring that medications retain their intended therapeutic effects while enhancing patient compliance and safety. The relevance of this market spans a wide range of applications, including oral and topical formulations, which cater…
Biopharmaceutical Excipient Market Growth Fueled by Rising Biologics Demand.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biopharmaceutical Excipient Manufacturing Market- by Type of Biologics (Antibodies, Vaccines, Cell Therapies and Other Biologics), Type of Excipient (Carbohydrates, Polymers, Solubilizers/Surfactants, Polyols, Proteins/Amino Acids and Others), Scale of Operation (Preclinical, Clinical and Commercial), Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
According to the latest research by InsightAce Analytic, the global Biopharmaceutical Excipient Manufacturing market…
Biopharmaceutical Excipient Manufacturing: Driving Efficiency in Pharmaceutical …
"Biopharmaceutical Excipient Manufacturing Market" in terms of revenue was estimated to be worth $1,372.7 Mn in 2023 and is poised to reach $2,892.5 Mn by 2031, growing at a CAGR of 9.82% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1197
Market Analysis:
Biopharmaceutical excipients serve an important role in biologic drug formulation by stabilizing, delivering, and improving the performance of active pharmaceutical…
Isotope-Labeled Excipient Market Revenue, Insights, Overview, Outlook, Analysis
Isotope-Labeled Excipient Market
Isotopic labeling is a technique which identifies drug products and detects counterfeits. Over the globe, pharmaceutical companies face a major problem of drug counterfeit, and the adoption of isotope-labeled excipients helps in reducing such products which are either manufactured with no active pharmaceutical ingredients (API), wrong API, or an incorrect amount of API. Counterfeiting issues are a major concern in the pharmaceutical market owing to poor regulatory scenario,…
Global Pharmaceutical Excipient Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Pharmaceutical Excipient Market is projected to grow from USD 8.6 Billion in 2022 to USD 11.5 billion in 2027 at a CAGR of 5.9% from 2022 to 2027.
The increase in demand for oral solid pharmaceutical drugs, the emergence of novel therapeutics on account of the growing number of pharmaceutical companies, the rapidly growing pharmaceuticals market, and…
